- Home
- HMST vs OSUR Comparison
HMST vs OSUR Comparison
Compare HMST & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- OSUR
- Stock Information
- Founded
- HMST 1921
- OSUR 2000
- Country
- HMST United States
- OSUR United States
- Employees
- HMST N/A
- OSUR N/A
- Industry
- HMST Major Banks
- OSUR Medical/Dental Instruments
- Sector
- HMST Finance
- OSUR Health Care
- Exchange
- HMST Nasdaq
- OSUR Nasdaq
- Market Cap
- HMST 287.6M
- OSUR 289.4M
- IPO Year
- HMST 2012
- OSUR 1986
- Fundamental
- Price
- HMST $10.98
- OSUR $3.64
- Analyst Decision
- HMST Buy
- OSUR Hold
- Analyst Count
- HMST 2
- OSUR 2
- Target Price
- HMST $14.75
- OSUR $5.50
- AVG Volume (30 Days)
- HMST 151.4K
- OSUR 1.0M
- Earning Date
- HMST 01-27-2025
- OSUR 11-06-2024
- Dividend Yield
- HMST N/A
- OSUR N/A
- EPS Growth
- HMST N/A
- OSUR N/A
- EPS
- HMST N/A
- OSUR 0.15
- Revenue
- HMST $169,710,000.00
- OSUR $224,263,000.00
- Revenue This Year
- HMST N/A
- OSUR N/A
- Revenue Next Year
- HMST $12.08
- OSUR N/A
- P/E Ratio
- HMST N/A
- OSUR $24.13
- Revenue Growth
- HMST N/A
- OSUR N/A
- 52 Week Low
- HMST $8.09
- OSUR $3.58
- 52 Week High
- HMST $16.10
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- HMST 41.70
- OSUR 39.12
- Support Level
- HMST $10.60
- OSUR $3.76
- Resistance Level
- HMST $11.95
- OSUR $3.70
- Average True Range (ATR)
- HMST 0.47
- OSUR 0.17
- MACD
- HMST -0.03
- OSUR -0.02
- Stochastic Oscillator
- HMST 29.73
- OSUR 10.00
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.